BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 9952380)

  • 1. Incidence of immune recovery vitritis in cytomegalovirus retinitis patients following institution of successful highly active antiretroviral therapy.
    Karavellas MP; Plummer DJ; Macdonald JC; Torriani FJ; Shufelt CL; Azen SP; Freeman WR
    J Infect Dis; 1999 Mar; 179(3):697-700. PubMed ID: 9952380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune recovery vitritis and uveitis in AIDS: clinical predictors, sequelae, and treatment outcomes.
    Karavellas MP; Azen SP; MacDonald JC; Shufelt CL; Lowder CY; Plummer DJ; Glasgow B; Torriani FJ; Freeman WR
    Retina; 2001; 21(1):1-9. PubMed ID: 11217922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of anti-cytomegalovirus therapy on the incidence of immune recovery uveitis in AIDS patients with healed cytomegalovirus retinitis.
    Song MK; Azen SP; Buley A; Torriani F; Cheng L; Chaidhawangul S; Ozerdem U; Scholz B; Freeman WR
    Am J Ophthalmol; 2003 Oct; 136(4):696-702. PubMed ID: 14516810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term follow-up of patients with AIDS treated with parenteral cidofovir for cytomegalovirus retinitis: the HPMPC Peripheral Cytomegalovirus Retinitis Trial. The Studies of Ocular Complications of AIDS Research Group in collaboration with the AIDS Clinical Trials Group.
    AIDS; 2000 Jul; 14(11):1571-81. PubMed ID: 10983644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of immune recovery uveitis in patients with AIDS and cytomegalovirus retinitis.
    Kempen JH; Min YI; Freeman WR; Holland GN; Friedberg DN; Dieterich DT; Jabs DA;
    Ophthalmology; 2006 Apr; 113(4):684-94. PubMed ID: 16581429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous cidofovir for compassionate use in AIDS patients with cytomegalovirus retinitis. Spanish Cidofovir Study Group.
    Berenguer J; Mallolas J
    Clin Infect Dis; 2000 Jan; 30(1):182-4. PubMed ID: 10619750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-dose intravitreal cidofovir (HPMPC) therapy of cytomegalovirus retinitis in patients with acquired immune deficiency syndrome.
    Taskintuna I; Rahhal FM; Arevalo JF; Munguia D; Banker AS; De Clercq E; Freeman WR
    Ophthalmology; 1997 Jun; 104(6):1049-57. PubMed ID: 9186448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anterior uveitis and hypotony after intravenous cidofovir for the treatment of cytomegalovirus retinitis.
    Akler ME; Johnson DW; Burman WJ; Johnson SC
    Ophthalmology; 1998 Apr; 105(4):651-7. PubMed ID: 9544639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immune recovery vitritis].
    Dujić M; Jevtović D
    Srp Arh Celok Lek; 2007; 135(9-10):513-5. PubMed ID: 18088034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of combination antiretroviral therapy on cytomegalovirus retinitis.
    Banker AS; Patel A
    Indian J Ophthalmol; 2002 Mar; 50(1):29-33. PubMed ID: 12090084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of cytomegalovirus (CMV) retinitis in second eyes of patients with the acquired immune deficiency syndrome and unilateral CMV retinitis.
    Kempen JH; Jabs DA; Wilson LA; Dunn JP; West SK
    Am J Ophthalmol; 2005 Jun; 139(6):1028-34. PubMed ID: 15953432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cystoid macular edema following immune recovery and treatment with cidofovir for cytomegalovirus retinitis.
    Kersten AJ; Althaus C; Best J; Sundmacher R
    Graefes Arch Clin Exp Ophthalmol; 1999 Nov; 237(11):893-6. PubMed ID: 10541898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of reactivation of cytomegalovirus retinitis in patients healed after treatment with highly active antiretroviral therapy.
    Song MK; Karavellas MP; MacDonald JC; Plummer DJ; Freeman WR
    Retina; 2000; 20(2):151-5. PubMed ID: 10783947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Fabrication of cidofovir ampules for intravitreal injections for cytomegalovirus retinitis].
    Schleppy CA; Tritten JJ
    Rev Med Suisse Romande; 1998 Mar; 118(3):263-5. PubMed ID: 9594603
    [No Abstract]   [Full Text] [Related]  

  • 15. Cidofovir approved.
    PI Perspect; 1996 Sep; (No 19):14-5. PubMed ID: 11363898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ocular complications of intravenous cidofovir for cytomegalovirus retinitis in patients with AIDS.
    Bainbridge JW; Raina J; Shah SM; Ainsworth J; Pinching AJ
    Eye (Lond); 1999 Jun; 13 ( Pt 3a)():353-6. PubMed ID: 10624432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of reactivation of cytomegalovirus retinitis in an AIDS patient, during and after stopping long-term cidofovir treatment: case report.
    Papastamopoulos V; Botsis C; Paparizos VA; Kyriakis KP; Zagoraios Y; Stavrianeas NG
    J Chemother; 2000 Jun; 12(3):258-60. PubMed ID: 10877523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of and risk factors for visual acuity loss among patients with AIDS and cytomegalovirus retinitis in the era of highly active antiretroviral therapy.
    Thorne JE; Jabs DA; Kempen JH; Holbrook JT; Nichols C; Meinert CL;
    Ophthalmology; 2006 Aug; 113(8):1432-40. PubMed ID: 16766032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of reactivation of cytomegalovirus (CMV) retinitis after stopping CMV maintenance therapy in AIDS patients with sustained elevations in CD4 T cells in response to highly active antiretroviral therapy.
    Macdonald JC; Torriani FJ; Morse LS; Karavellas MP; Reed JB; Freeman WR
    J Infect Dis; 1998 May; 177(5):1182-7. PubMed ID: 9593001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune recovery uveitis in AIDS patients with cytomegalovirus retinitis treated with highly active antiretroviral therapy in Venezuela.
    Arevalo JF; Mendoza AJ; Ferretti Y
    Retina; 2003 Aug; 23(4):495-502. PubMed ID: 12972761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.